Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Sales | 0 | 100 | 0 | 0 | 0 |
| Gross Profit | N/A | 100 | 0 | N/A | 0 |
| Operating Expenses | 1,589 | 1,853 | 1,070 | 1,044 | 1,290 |
| Operating Income | -1,589 | -1,753 | -1,070 | -1,044 | -1,290 |
| Interest Expense | 0 | 32 | 50 | 0 | 30 |
| Other Income | -31 | 0 | -820 | 208 | 50 |
| Pre-tax Income | -1,620 | -1,784 | -1,940 | -837 | -1,270 |
| Net Income Continuous | -1,620 | -1,784 | -1,995 | -837 | -1,270 |
| Net Income | $-1,620 | $-1,784 | $-1,995 | $-837 | $-1,270 |
| EPS Basic Total Ops | -384.00 | -624.00 | -800.00 | -544.00 | -800.00 |
| EPS Basic Continuous Ops | -376.33 | -618.49 | -831.25 | -462.84 | -846.67 |
| EPS Diluted Total Ops | -384.00 | -624.00 | -800.00 | -544.00 | -800.00 |
| EPS Diluted Continuous Ops | -376.33 | -618.49 | -831.25 | -462.84 | -846.67 |
| EBITDA(a) | $-1,511 | $-1,968 | $-982 | $-842 | $-1,220 |